Diffuse large B-cell lymphoma
M Martelli, AJM Ferreri, C Agostinelli, A Di Rocco… - Critical reviews in …, 2013 - Elsevier
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoid malignancy in adults
accounting for 31% of all NHL in Western Countries. Following, morphological, biological …
accounting for 31% of all NHL in Western Countries. Following, morphological, biological …
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
SF Barrington, R Kluge - European journal of nuclear medicine and …, 2017 - Springer
Abstract PET using 18 F-FDG for treatment monitoring in patients with lymphoma is one of
the most well-developed clinical applications. PET/CT is nowadays used during treatment to …
the most well-developed clinical applications. PET/CT is nowadays used during treatment to …
Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group
SF Barrington, NG Mikhaeel, L Kostakoglu… - Journal of clinical …, 2014 - ascopubs.org
Purpose Recent advances in imaging, use of prognostic indices, and molecular profiling
techniques have the potential to improve disease characterization and outcomes in …
techniques have the potential to improve disease characterization and outcomes in …
Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL
NG Mikhaeel, D Smith, JT Dunn, M Phillips… - European journal of …, 2016 - Springer
Background The study objectives were to assess the prognostic value of quantitative PET
and to test whether combining baseline metabolic tumour burden with early PET response …
and to test whether combining baseline metabolic tumour burden with early PET response …
Report on the first international workshop on interim-PET scan in lymphoma
M Meignan, A Gallamini, M Meignan… - Leukemia & …, 2009 - Taylor & Francis
An international workshop, under the auspices of Group d'Etude des Lymphomes de l'Adulte
(GELA) took place in Deauville, France, in April 3–4, 2009. The European experts with a …
(GELA) took place in Deauville, France, in April 3–4, 2009. The European experts with a …
Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma
SF Barrington, W Qian, EJ Somer… - European journal of …, 2010 - Springer
Purpose To determine if PET reporting criteria for the Response Adapted Treatment in
Hodgkin Lymphoma (RATHL) trial could enable satisfactory agreement to be reached …
Hodgkin Lymphoma (RATHL) trial could enable satisfactory agreement to be reached …
Role of functional imaging in the management of lymphoma
BD Cheson - Journal of Clinical Oncology, 2011 - ascopubs.org
18-F-fluorodeoxyglucose (FDG)–positron emission tomography (PET), and more recently
PET/computed tomography (CT), is the most sensitive and specific imaging technique …
PET/computed tomography (CT), is the most sensitive and specific imaging technique …
An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax
E Itti, M Meignan, A Berriolo-Riedinger, A Biggi… - European journal of …, 2013 - Springer
Purpose The role of interim PET/CT in guiding therapeutic strategies in diffuse large B-cell
lymphoma (DLBCL) is debated, mainly because interpretation rules vary among centres …
lymphoma (DLBCL) is debated, mainly because interpretation rules vary among centres …
SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma
RO Casasnovas, M Meignan… - Blood, The Journal …, 2011 - ashpublications.org
The prognostic value of interim positron emission tomography (PET) interpreted according to
visual criteria is a matter of debate in diffuse large B-cell lymphoma (DLBCL). Maximal …
visual criteria is a matter of debate in diffuse large B-cell lymphoma (DLBCL). Maximal …
Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP
P Pregno, A Chiappella, M Bellò, B Botto… - Blood, The Journal …, 2012 - ashpublications.org
Role of interim-PET (I-PET) in diffuse large B-cell Lymphoma (DLBCL) is controversial. To
determine predictive value of I-PET on progression-free survival (PFS), we enrolled 88 first …
determine predictive value of I-PET on progression-free survival (PFS), we enrolled 88 first …